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Gangliosides are glycosphingolipids that bear one or more sialic acid residues. This family of 
amphipathic molecules resides in the outer layer of cell membranes and is especially enriched 
in presynaptic nerve endings (for review, see Plomp and Willison, 2009). Hence, gangliosides 
have been hypothesized to play important roles in synaptic transmission, possibly through 
affecting presynaptic voltage-gated ion channels, Ca2+-homeostasis and/or surface charge. 
However, at the neuromuscular junction (NMJ) of transgenic mice lacking major subsets of 
gangliosides (Fig. 1), we have previously shown that presence of the complete family of 
gangliosides is not strictly required for functional synaptic transmission. Electrophysiological 
measurement of acetylcholine (ACh) release at NMJs of GM2/GD2-synthase knockout 
(GM2s-KO), GD3-synthase knockout (GD3s-KO), or compound null-mutant mice lacking 
both GM2/GD2- and GD3-synthase (dKO), showed only subtle changes and no failure of 
synaptic transmission was observed (Bullens et al., 2002; Zitman et al., 2008; Zitman et al., 
2009). This suggests a fine-tuning role for gangliosides in transmitter release, rather than their 
presence being an absolute requirement. Alternatively, the different types of gangliosides 
might act mutually compensatory in supporting transmitter release. Such a compensatory 
action of GM3 ganglioside might explain the redundancy we found for the other gangliosides, 
because in all three investigated transgenic strains at least this ganglioside remains present in 
the neural membrane (Fig. 1), most likely at highly accumulated level (Inoue et al., 2002). We 
here acutely removed the sialic acid component of this only remaining ganglioside at dKO 
NMJs, thereby creating a ganglioside-free nerve terminal, and studied the effect on transmitter 
release.  
Male and female dKO mice (Inoue et al., 2002; Zitman et al., 2008) were used in the 
experiments, at ~11 weeks of age and 22.9 ± 1.1 g body weight. Mice were killed by CO2 
asphyxiation. Left and right hemidiaphragms with phrenic nerves were dissected and pinned 
out in Ringer’s medium (119 mM NaCl, 4.5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 1mM 
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NaH2PO4, 23 mM NaHCO3, 11 mM glucose, pH 7.4), pre-gassed with 95% O2/5% CO2. 
Animal experiments were carried out according to Dutch law and Leiden University 
guidelines. 
dKO phrenic nerve-hemidiaphragm preparations (6 left- and 4 right-hemidiaphragms from 
n=10 dKO mice) were treated with 2 units neuraminidase type V from Clostridium 
perfringens (Sigma-Aldrich, Zwijndrecht, The Netherlands) in 1 ml Ringer’s medium for 1 h 
at 32 °C. This disrupts GM3 by cleaving the α2,3-link between the sialic acid and galactose 
molecule (Perillo et al., 1994). We used tissue from dKO mice because neuraminidase 
treatment of wild-type tissue will not induce complete ganglioside ablation due to the inability 
of the neuraminidase to desialylate GM1 (Perillo et al., 1994). The contralateral 
hemidiaphragm from each mouse was incubated as a control in Ringer's medium only. 
Preparations were then rinsed in Ringer’s medium for 10 min. Subsequently, μ-conotoxin-
GIIIB (3 μM; Scientific Marketing Associates, Barnet, Herts, UK) was added to block 
voltage-gated Na+ channels on the muscle membrane in order to prevent muscle action 
potentials and contraction. ACh release at NMJs at room temperature (20-22 C) was assessed 
using an intracellular electrophysiological method, as described before (Zitman et al., 2008), 
recording endplate potentials (EPPs, the postsynaptic responses resulting from nerve action 
potential-evoked ACh release following supramaximal stimulation of the phrenic nerve) and 
miniature EPPs (MEPPs, the responses resulting from spontaneous uniquantal release). The 
quantal content (i.e. the number of ACh quanta released per nerve impulse) was calculated 
from EPP and MEPP amplitudes (Zitman et al., 2008). Ten NMJs were sampled per muscle 
per experimental condition and at least 30 EPPs and 40 MEPPs were sampled per NMJ. Data 
is expressed as group mean ± S.E.M. (n=10 mice) of the mean muscle values calculated from 
the mean NMJ values. Statistical significance of differences between neuraminidase-treated 
and control groups was analyzed with paired Student’s t-tests. 
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 The disruption of GM3 at the dKO NMJ by neuraminidase caused a 16% increase of 
quantal content at 0.3 Hz nerve stimulation (control 42.3 ± 2.1 and neuraminidase-treated 49.1 
± 1.6; p<0.05; Fig. 2A). Spontaneous uniquantal ACh release, measured as MEPP frequency, 
showed a tendency of increase in the neuraminidase-treated NMJs, but this was not 
statistically significant (p=0.28, Fig. 2B). During high rate (40 Hz) nerve stimulation, ACh 
release at neuraminidase-treated dKO NMJs became more depressed than that at control dKO 
NMJs. The rundown level of EPPs (calculated as the mean amplitude of the 21st – 35th EPP, 
expressed as percentage of the first EPP of the train) at NMJs in neuraminidase-treated tissue 
was 67.3  1.5%, compared to 72.1  0.7% at NMJs of untreated dKO muscles (p<0.05; Fig. 
2C-E). For comparison, EPP rundown level at wild-type NMJs under comparable 
experimental conditions in our previous study was 80.9  1.2% (Zitman et al., 2008). 
Furthermore, the increase of the second EPP of the 40 Hz evoked train, compared to the first 
EPP (i.e. 25 ms paired-pulse facilitation), was lower in the neuraminidase-treated group (3.35 
 0.66% at control vs. 0.32  0.50% at neuraminidase-treated dKO NMJs; p<0.01; Fig. 2F). 
These results show that acute absence of all gangliosides by in vitro disruption of GM3, the 
only remaining type of ganglioside at dKO NMJs, at the one hand increases presynaptic 
neurotransmitter release by enhancing the amount of ACh released per nerve impulse but, on 
the other hand, reduces release by causing a more pronounced rundown during high rate 
stimulation. It is yet unclear how gangliosides affect ACh release in this way. Possibly it 
involves a modulatory effect of the negative electrical charges carried by sialic acid molecules 
of gangliosides on the presynaptic Cav2.1 channels that mediate neurotransmitter release at 
the NMJ (Kaja et al., 2007). This type of channel has been shown to co-localize with 
gangliosides in lipid rafts (Taverna et al., 2004), which may facilitate interaction. 
Furthermore, experiments using anti-ganglioside antibodies suggest a relationship between 
gangliosides and Cav2.1 channels (Nakatani et al., 2009; Ortiz et al., 2001). Cav2.1 channel 
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behaviour is one important determinant of EPP rundown level at high intensity use of NMJs 
(Kaja et al., 2005). Another indication for possible modulation of Cav2.1 channels by 
gangliosides is the reduction of 25 ms paired-pulse facilitation, because this phenomenon of 
short term synaptic plasticity is highly dependent on intraterminal accumulation of Ca2+, 
mainly determined by influx levels and intracellular buffering capacity. Increased Ca2+ influx 
following neuraminidase treatment has also been shown in cardiac myocytes, possibly 
through opening of 'leak' channels (Marengo et al., 1998). Alternatively, the sialic acids of 
gangliosides adjacent to presynaptic Cav2.1 channels at the motor nerve terminal might act to 
locally sequester extracellular Ca2+, making it available upon high intensity use of the synapse 
in order to enable sustained transmitter release. 
Although we are not aware of any sialylated proteins important for presynaptic transmitter 
release at mouse NMJs, we can not completely exclude that (part) of the effects of 
neuraminidase treatment on synaptic transmission at the dKO NMJs was due to desialylation 
of such putative sialoproteins. Sialic acid removal from hippocampal voltage-gated Na+ 
channels has been shown to increase action potential firing threshold (Isaev et al., 2007). 
However, such an effect occurring in phrenic nerves of our nerve-muscle preparations would 
be irrelevant because of the supramaximal stimulation we applied.  
In view of the rather modest magnitude of the effects of total ganglioside ablation on ACh 
release, in combination with the increased initial quantal content, compensating for the 
reduced release at high rate stimulation, it is not to be expected that successful neuromuscular 
transmission becomes endangered. Synaptic transmission at the NMJ has a large safety factor 
(Wood and Slater, 2001), and in line with this we observed a sustained tetanic muscle 
contraction upon 40 Hz nerve stimulation when visually inspecting dKO hemidiaphragms 
directly after the neuraminidase treatment. 
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In conclusion, we show that gangliosides play a role in transmitter release at the NMJ, albeit 
a rather modest one. Although an indispensable role for gangliosides in neurotransmission 
was hypothesized previously, they apparently are not absolutely required. The almost normal 
ACh release levels observed earlier at NMJs of GM2s-KO, GD3s-KO and dKO mice (Bullens 
et al., 2002; Zitman et al., 2008; Zitman et al., 2009) are likely due to compensatory effects of 
the remaining subsets of gangliosides, or GM3 ganglioside alone, respectively. It must be 
noted that we here studied synaptic effects of acute ablation of the last remaining ganglioside 
at dKO NMJs and that it can not be excluded that long-term overall ganglioside deficiency 
has more severe synaptic effects. Such effects may underlie the severe neurodegenerative 
symptoms and premature death of transgenic mice lacking both GM2-synthase and GM3-
synthase, which have permanently blocked in vivo synthesis of all gangliosides (Yamashita et 
al., 2005). In humans it was found that a lack of synthesis of the major gangliosides, due to a 
autosomal recessive truncation mutation in the SIAT9 gene that encodes GM3-synthase, 
resulted in infantile-onset epilepsy associated with developmental stagnation and blindness 
(Simpson et al., 2004). The affected children show distorted reflexes and one case of startle 
myoclonus was observed. Neuromuscular transmission failure has not specifically been 
reported in these patients. 
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Figure legends 
Figure 1.  Ganglioside synthesis scheme with indication of the subsets lacking in GM2s-KO 
and GD3s-KO mice. dKO mice only express GM3. 
Figure 2. Electrophysiological measurement of ACh release at diaphragm NMJs of dKO 
mice (n=10) to assess the effect of neuraminidase (N'ase). Controls were sham-incubated 
without neuraminidase. For comparison, the values of synaptic parameters obtained at wild-
type NMJ (without neuraminidase treatment) in our previous study (Zitman et al., 2008), have 
been added to the panels (gray bars, n=4 mice). Data is expressed as group means  S.E.M. 
(bars) and hemidiaphragm pairs from individual mice (gray dots with connecting line). (A) 
Quantal content at 0.3 Hz nerve stimulation increased 16% (p<0.05) by the neuraminidase 
treatment. (B) MEPP frequency showed an increase, but this was not statistically significant 
(p=0.28). (C) Rundown level of EPPs upon 40 Hz nerve stimulation was more pronounced 
(p<0.05). (D) Mean EPP amplitude profiles during 40 Hz nerve stimulation (E) 
Representative examples of 40 Hz EPPs at control and neuraminidase-treated NMJs. (F) 
Paired-pulse (25 ms) facilitation became smaller (p<0.01). 
*p<0.05; **p<0.01;  n.s.: not statistically significant 
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Figure 2 
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